Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
2 Nov, 26
EADV 2026
These key abstracts presented at EADV Congress 2026 highlighted advances in acne pathogenesis, microbiome research, isotretinoin safety and optimization, and real-world treatment outcomes, reinforcing the move toward personalized, evidence-based dermatologic care.
29 Oct, 26EADV 2026
New studies presented during EADV 2026 demonstrated improved psoriasis outcomes with combined metabolic and biologic therapy, sustained benefits with secukinumab, and the value of multidisciplinary patient management.
30 Oct, 26Clin Infect. Dis.
- Analysis of 777,512 Indian adults with extrapulmonary tuberculosis showed >10-fold variation in in-treatment mortality by disease site
- Mortality risk was highest in tuberculous meningitis (aOR 12.48), followed by miliary TB (5.17) and pericardial TB (3.86) versus lymph node TB
- Effects of HIV, diabetes, alcohol, and tobacco use on mortality differed across sites, supporting risk-stratified care.
30 Oct, 26
A 9-year-old girl with moderate persistent asthma experienced frequent wheezing and exacerbations despite ICS therapy, triggered by exercise, cold air, and environmental allergens. An integrative approach improved asthma control. Click here to read the treatment.
30 Oct, 26
A 43-year-old woman with long-standing T2D developed progressive NPDR despite good glycemic control. DME developed in the right eye after switching to SC semaglutide. Click here to read the treatment.
27 Oct, 26Diabetes Obes Metab.
- The study demonstrated a significant nonlinear association between eGFR & all-cause mortality in 595 DFU patients
- Mortality increased markedly with eGFR <45 mL/min/1.73 m², adjusted HRs were 2.59 for eGFR 30-<45 & 4.67 for eGFR <30 vs ≥60 mL/min/1.73 m²
- Advanced age, lower BMI, & hypoalbuminemia independently predicted mortality
- Routine eGFR testing supports early DFU risk assessment.
Featured
26 Oct, 26
26 Oct, 26
26 Oct, 26
